AAAAAA

   
Results: 1-18 |
Results: 18
Regulation of the alpha-secretase ADAM10 by its prodomain and proprotein convertases
Authors: Anders, A Gilbert, S Garten, W Postina, R Fahrenholz, F
Citation: A. Anders et al., Regulation of the alpha-secretase ADAM10 by its prodomain and proprotein convertases, FASEB J, 15(8), 2001, pp. NIL_39-NIL_59
The Oxytocin Receptor System: Structure, function, and regulation
Authors: Gimpl, G Fahrenholz, F
Citation: G. Gimpl et F. Fahrenholz, The Oxytocin Receptor System: Structure, function, and regulation, PHYSIOL REV, 81(2), 2001, pp. 629-683
Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the alpha-secretase ADAM 10
Authors: Kojro, E Gimpl, G Lammich, S Marz, W Fahrenholz, F
Citation: E. Kojro et al., Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the alpha-secretase ADAM 10, P NAS US, 98(10), 2001, pp. 5815-5820
Molecular modelling study of the role of cholesterol in the stimulation ofthe oxytocin receptor
Authors: Politowska, E Kazmierkiewicz, R Wiegand, V Fahrenholz, F Ciarkowski, J
Citation: E. Politowska et al., Molecular modelling study of the role of cholesterol in the stimulation ofthe oxytocin receptor, ACT BIOCH P, 48(1), 2001, pp. 83-93
Cholesterol binds to synaptophysin and is required for biogenesis of synaptic vesicles
Authors: Thiele, C Hannah, MJ Fahrenholz, F Huttner, WB
Citation: C. Thiele et al., Cholesterol binds to synaptophysin and is required for biogenesis of synaptic vesicles, NAT CELL BI, 2(1), 2000, pp. 42-49
Regulation of receptor function by cholesterol
Authors: Burger, K Gimpl, G Fahrenholz, F
Citation: K. Burger et al., Regulation of receptor function by cholesterol, CELL MOL L, 57(11), 2000, pp. 1577-1592
Oxytocin receptors and cholesterol: interaction and regulation
Authors: Gimpl, G Burger, K Politowska, E Ciarkowski, J Fahrenholz, F
Citation: G. Gimpl et al., Oxytocin receptors and cholesterol: interaction and regulation, EXP PHYSIOL, 85, 2000, pp. 41S-49S
Misfolded vasopressin V-2 receptors caused by extracellular point mutations entail congential nephrogenic diabetes insipidus
Authors: Postina, R Ufer, E Pfeiffer, R Knoers, NVAM Fahrenholz, F
Citation: R. Postina et al., Misfolded vasopressin V-2 receptors caused by extracellular point mutations entail congential nephrogenic diabetes insipidus, MOL C ENDOC, 164(1-2), 2000, pp. 31-39
Expression and cell-specific localization of the cholecystokinin B/gastrinreceptor in the human stomach
Authors: Kulaksiz, H Arnold, R Goke, B Maronde, E Meyer, M Fahrenholz, F Forssmann, WG Eissele, R
Citation: H. Kulaksiz et al., Expression and cell-specific localization of the cholecystokinin B/gastrinreceptor in the human stomach, CELL TIS RE, 299(2), 2000, pp. 289-298
A mutation in the second intracellular loop of the pituitary adenylate cyclase activating polypeptide type I receptor confers constitutive receptor activation
Authors: Cao, YJ Gimpl, G Fahrenholz, F
Citation: Yj. Cao et al., A mutation in the second intracellular loop of the pituitary adenylate cyclase activating polypeptide type I receptor confers constitutive receptor activation, FEBS LETTER, 469(2-3), 2000, pp. 142-146
Human oxytocin receptors in choiesterol-rich vs. cholesterol-poor microdomains of the plasma membrane
Authors: Gimpl, G Fahrenholz, F
Citation: G. Gimpl et F. Fahrenholz, Human oxytocin receptors in choiesterol-rich vs. cholesterol-poor microdomains of the plasma membrane, EUR J BIOCH, 267(9), 2000, pp. 2483-2497
2D6, specific to rat pituitary adenylate cyclase activating polypeptide type I receptor (PACAP receptor)
Authors: Fahrenholz, F
Citation: F. Fahrenholz, 2D6, specific to rat pituitary adenylate cyclase activating polypeptide type I receptor (PACAP receptor), HYBRIDOMA, 18(5), 1999, pp. 467-467
5C1, specific to rat pituitary adenylate cyclase activating polypeptide type I receptor (PACAP receptor)
Authors: Fahrenholz, F
Citation: F. Fahrenholz, 5C1, specific to rat pituitary adenylate cyclase activating polypeptide type I receptor (PACAP receptor), HYBRIDOMA, 18(5), 1999, pp. 468-468
Production and characterization of monoclonal antibodies to pituitary adenylate cyclase activating polypeptide type I receptor
Authors: Zvirbliene, A Zvirblis, G Cao, YJ Fahrenholz, F
Citation: A. Zvirbliene et al., Production and characterization of monoclonal antibodies to pituitary adenylate cyclase activating polypeptide type I receptor, HYBRIDOMA, 18(4), 1999, pp. 335-342
Constitutive and regulated alpha-secretase cleavage of Alzheimer's amyloidprecursor protein by a disintegrin metalloprotease
Authors: Lammich, S Kojro, E Postina, R Gilbert, S Pfeiffer, R Jasionowski, M Haass, C Fahrenholz, F
Citation: S. Lammich et al., Constitutive and regulated alpha-secretase cleavage of Alzheimer's amyloidprecursor protein by a disintegrin metalloprotease, P NAS US, 96(7), 1999, pp. 3922-3927
Non-genomic effects of progesterone on the signaling function of G protein-coupled receptors
Authors: Burger, K Fahrenholz, F Gimpl, G
Citation: K. Burger et al., Non-genomic effects of progesterone on the signaling function of G protein-coupled receptors, FEBS LETTER, 464(1-2), 1999, pp. 25-29
Structural requirements for V-2 vasopressin receptor proteolytic cleavage
Authors: Kojro, E Postina, R Gilbert, S Bender, F Krause, G Fahrenholz, F
Citation: E. Kojro et al., Structural requirements for V-2 vasopressin receptor proteolytic cleavage, EUR J BIOCH, 266(2), 1999, pp. 538-548
Direct identification of the agonist binding site in the human brain cholecystokinin(B) receptor
Authors: Anders, J Bluggel, M Meyer, HE Kuhne, R ter Laak, AM Kojro, E Fahrenholz, F
Citation: J. Anders et al., Direct identification of the agonist binding site in the human brain cholecystokinin(B) receptor, BIOCHEM, 38(19), 1999, pp. 6043-6055
Risultati: 1-18 |